4
Changes in Ownership
Matinas BioPharma Holdings, Inc. Filed Acc 0001493152-23-045167
Options or other derivatives
- Chief Development Officer acquired 1,300,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Matkovits Theresa Chief Development Officer | 2023-12-15 | Grant or award · Stock Option (right to Buy) | +1,300,000 | 1,300,000 | D | ||
Loading xslF345X05/ownership.xml…